Has Cristian Ionita received payments from drug or device companies?

Yes. Drug and device makers reported $15,389 in general payments to Cristian Ionita across 15 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cristian Ionita did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cristian Ionita come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cristian Ionita

Neurology with Special Qualifications in Child Neurology · Hartford, CTNPI 1043300544

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,615 of the $15,389 with a category attached, or 82.0%. Biogen accounts for 97.6% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2019 at $13,116 and has fallen 99.9% since, to $17 in 2022.

$15,389in general payments, 2019–2025

Across 15 payments — averaging $1025.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Biogen$15K
PTC Therapeutics, Inc.$213
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$135
Biohaven Pharmaceutical Holding Company Ltd.$17
Travere Therapeutics, Inc.$1

$318,896in research payments, 2019–2025

Across 88 payments — averaging $3623.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Eli Lilly$128K
H. Lundbeck A S$60K
Roche Products Limited$42K
Hoffmann-la Roche Limited$32K
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)$26K
PTC Therapeutics, Inc.$18K
plus $13K from 2 others

What the payments were for

Consulting fees$2001%
Speaking & faculty fees$12,61582%
Travel & lodging$2,46116%
Food & beverage$1121%
Education$10%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Biogen	8	$15,022
PTC Therapeutics, Inc.	2	$213
Novartis Gene Therapies, Inc. (fka Avexis, Inc.)	3	$135
Biohaven Pharmaceutical Holding Company Ltd.	1	$17
Travere Therapeutics, Inc.	1	$1

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SPINRAZA$14,941

How this compares

$15,389 in reported general payments places this provider in the 75th percentile of 28 neurology with special qualifications in child neurology providers in Connecticut.

See all neurology with special qualifications in child neurology providers in Connecticut →

Other neurology with special qualifications in child neurology in Hartford

Jennifer Madan CohenHartford$10K
Lila WordenHartford$270
Louisa KalsnerHartford$191
Richard YoungHartford$147
Francis DimarioHartford$146
Mark SchomerHartford$73
Jong RhoNew Haven$55K
Susan LevyGuilford$38K
Francine TestaGuilford$38K
Alok BhargavaFarmington$27K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →